[Neurocytoprotection advances in reperfusion therapy]

Area of Science:

• Neurology
• Vascular Neurology
• Neuroscience

Background:

• Acute stroke is a leading global cause of death and disability.
• Ischemic stroke (IS) is the most common type, involving complex brain tissue damage.
• Reperfusion therapy (RT) is a key treatment for acute IS, with proven efficacy and safety.

Purpose of the Study:

• To review current trials investigating neurocytoprotection combined with reperfusion therapy in IS patients.
• To explore the potential of combining RT with neurocytoprotection to improve treatment outcomes.
• To analyze strategies for preserving brain tissue in the ischemic penumbra.

Main Methods:

• Systematic review of randomized clinical trials.
• Analysis of neuroimaging techniques (CT-perfusion, MRI) for RT selection.
• Evaluation of neurocytoprotective strategies in conjunction with RT.

Main Results:

• Novel neuroimaging has expanded RT eligibility in IS patients.
• Combining RT with neurocytoprotection is a promising strategy.
• Preserving ischemic penumbra tissue is a key therapeutic goal.

Conclusions:

• Neurocytoprotection combined with RT holds potential to enhance treatment efficacy and safety for IS.
• Further research into combined therapies is warranted to optimize stroke management.
• Expanding RT criteria through advanced imaging and protective strategies is crucial.